THOUSAND OAKS, Calif.,
Sept. 11, 2017 /PRNewswire/
-- Amgen (NASDAQ:AMGN) will present at the Bank of America
Merrill Lynch Global Healthcare Conference at 9:45 a.m. GMT on Thursday,
Sept. 14, 2017, in London.
David W. Meline, executive vice
president and chief financial officer at Amgen, will present at the
conference. Live audio of the presentation can be accessed from the
Events Calendar on Amgen's website, www.amgen.com, under Investors.
A replay of the webcast will also be available on Amgen's website
for at least 90 days following the event.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Kristen Neese, 805-313-8267
(media)
Arvind Sood, 805-447-1060
(investors)
View original content with
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-global-healthcare-conference-300517272.html
SOURCE Amgen